About the job
Join Axsome Therapeutics, a trailblazer in biopharmaceutical innovation focused on advancing treatments for central nervous system (CNS) disorders. We are dedicated to addressing significant gaps in care through groundbreaking scientific discoveries and developing unique therapies with novel mechanisms of action that significantly improve patient outcomes. Our leading neuroscience portfolio features FDA-approved solutions for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine, alongside several late-stage development initiatives aimed at a wide spectrum of serious neurological and psychiatric disorders affecting over 150 million individuals in the United States. Together, we are committed to tackling some of the most challenging brain-related issues, allowing patients and their families to thrive. For more information about our mission and vision, please visit www.axsome.com and connect with us on LinkedIn.

